D-1324-2020 Class II Terminated

Recalled by Glaxosmithkline Consumer Healthcare Holdings — Warren, NJ

Recall Details

Product Type
Drugs
Report Date
June 24, 2020
Initiation Date
May 28, 2020
Termination Date
January 24, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
629,796 bottles

Product Description

Gaviscon Extra Strength Liquid Antacid Extra Strength Cherry, 12 FL OZ. (355 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0574-41

Reason for Recall

Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.

Distribution Pattern

U.S.A. Nationwide

Code Information

Lot #: 0A26C1, Exp 12/31/2021; 0B10C1, Exp 1/31/2022; 8L19C1, Exp 10/31/2020; 8L27C1, Exp 10/31/2020; 9A28C1, Exp 12/31/2020; 9B18C1, Exp 1/31/2021; 9C19C1, Exp 2/28/2021; 9D09C1, Exp 3/31/2021; 9F20C1, Exp 5/31/2021; 9G24C1, Exp 6/30/2021; 9J09C1, Exp 8/31/2021; 9K29C1, Exp 9/30/2021; 9L05C1, Exp 9/30/2021